Constellation Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $1.52M | Buy |
10,900
+325
| +3% | +$45.2K | 0.28% | 75 |
|
|
2015
Q4 | $2.02M | Buy |
10,575
+25
| +0.2% | +$4.77K | 0.38% | 61 |
|
|
2015
Q3 | $1.65M | Buy |
10,550
+775
| +8% | +$121K | 0.34% | 67 |
|
|
2015
Q2 | $1.77M | Buy |
9,775
+450
| +5% | +$81.3K | 0.34% | 69 |
|
|
2015
Q1 | $1.62M | Buy |
9,325
+475
| +5% | +$82.3K | 0.31% | 73 |
|
|
2014
Q4 | $1.64M | Buy |
8,850
+325
| +4% | +$60.2K | 0.33% | 66 |
|
|
2014
Q3 | $1.41M | Sell |
8,525
-25
| -0.3% | -$4.15K | 0.31% | 72 |
|
|
2014
Q2 | $1.34M | Sell |
8,550
-50
| -0.6% | -$7.81K | 0.31% | 72 |
|
|
2014
Q1 | $1.31M | Buy |
8,600
+475
| +6% | +$72.2K | 0.32% | 72 |
|
|
2013
Q4 | $1.08M | Buy |
8,125
+600
| +8% | +$79.8K | 0.27% | 81 |
|
|
2013
Q3 | $874K | Buy |
7,525
+475
| +7% | +$55.2K | 0.27% | 87 |
|
|
2013
Q2 | $650K | Buy |
+7,050
| New | +$650K | 0.23% | 99 |
|